DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nefazodone
Nefazodone
Association of Selective Serotonin Reuptake Inhibitors with the Risk for Spontaneous Intracranial Hemorrhage
Report and Evidence Tables
Changing Medications Usually Is Not Complicated, but Problems Can Arise
Psychedelic Drugs
Tcas Versus Placebo - New Studies in the Guideline Update
1 Supplemental Figure 1: Illustration of Time-Varying
Providers | Medications for Depression
Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period
Antidepressant Medications: U.S. Food and Drug Administration
Antidepressants: Mechanism of Action, Toxicity and Possible Amelioration
Anafranil (Clomipramine Hydrochloride) Tablets 1 Name of the Medicine 2 Qualitative and Quant
Currently Prescribed Psychotropic Medications
Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: a Retrospective US Claims Study
Va / Dod Depression Practice Guideline Provider Care Card Antidepressant
Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: a Literature Review and a Proposal for a Novel Approach to Improve Practice
Piperazine Derivatives As Dangerous Abused Compounds
Letters to the Editor
Supplemental Digital Content 1 Search Strategy (First Conducted on January 17, 2014; Second Retrieval on November 5, 2014)
Top View
Current P SYCHIATRY
Antipsychotics and Antidepressants
Nefazodone | Memorial Sloan Kettering Cancer Center
(12) Patent Application Publication (10) Pub. No.: US 2009/0018115 A1 Gaddle Et Al
CCDAN Search Strategies (All Antidepressants)
Commonly Prescribed Psychotropic Medications
Antidepressant Medications
Therapeutic Class Overview Serotonin Modulators
The Pharmacologic Treatment of Depression
Antidepressants and Functional Gastrointestinal Disorders
Comments & Controversies
Antidepressants for Insomnia in Adults (Review)
Supplementary Content Title: the Impact of Anxiety and Depression
Antidepressant Medications: Use in Adults
Pharmacogenetics of Antidepressants and Antipsychotics
University of Alberta
1-(3-Chlorophenyl)Piperazine (Mcpp) in Accordance with Article 5
The Potential Role of Serotonergic Hallucinogens in Depression Treatment
Formulary for Non-IHSC Staffed Detention Facilities
Formulary and Prescribing Guidelines
Customs and Border Protection Medication Formulary
Quantitative Analysis of New Generation Antidepressants Using Gas Chromatography-Mass Spectrometry
Appendix & Tables
Table [1]: Definition of Reported Outcomes Study Outcome
A Drug Combination That Reduces Weight Gain Associated with Antidepressant Therapy
Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients
United States Patent (10) Patent No.: US 9,630,959 B2 Ando Et Al
Drug-Induced Mitochondrial Dysfunction: an Emerging Model for Idiosyncratic Drug Toxicity
Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment
Esketamine for Treatment-Resistant Major Depressive Disorder
1-(3-Chlorophenyl)Piperazine (Mcpp) Pre-Review Report
Full-Text Articles Assessed for Full-Text Articles Excluded, Eligibility (N = 78) (N = 113)
Nefazodone and Venlafaxine: Two New Agents for the Treatment of Depression Richard J
Examples of Medications with Effects on Serotonin
Cardiovascular Side Effects of Newer Antidepressants Yeni Antidepresanlar›N Kardiyovasküler Yan Etkileri
Beneficial and Harmful Effects of Antidepressants Versus Placebo
Clinical Inquiries from the FAMILY PRACTICE INQUIRIES NETWORK
Naltrexone Vs. Nefazodone for Treatment of Alcohol Dependence a Placebo-Controlled Trial Henry R
Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
LETTERS to the EDITOR Amitriptyline-Induced Anorgasmia
Drug Class Review Second-Generation Antidepressants
Piperazine (Mcpp)
Psychotropic Medication Side Effects